Sort

Search

01/06/2024 Evaluation of a new technique to fill the defect generated after conservative surgery for breast cancer
Garcia-Valdecasas, B, Matias, I, Capdevila, E, Isern, J, Guix, J, Llurba, E. Evaluation of a new technique to fill the defect generated after conservative surgery for breast cancer. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. 2024; 54DOI:. PMID:. IF:3.600(Q1/2D).
01/06/2024 Incorporation of sFlt1/PlGF in the diagnosis and classification of preeclampsia for improving maternal outcomes. A multicenter randomized controlled trial
Manau, PG, Oliva, AF, Garrido, C, Ullmo, J, Sanchez, O, Mora, J, Bonacina, E, Mendoza, M, Ruiz, A, Valle, L, Comas, M, Muñoz, B, Pelegay, MJ, Vila, M, Maroto, A, López, M, Romero, MA, Mazarico, E, Ricart, M, Vila, I, Martínez, JB, Jurado, J, Valldeperas, L, Llurba, E. Incorporation of sFlt1/PlGF in the diagnosis and classification of preeclampsia for improving maternal outcomes. A multicenter randomized controlled trial. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. 2024; 54DOI:. PMID:. IF:3.600(Q1/2D).
01/06/2024 Emerging variants, unique phenotypes, and transcriptomic signatures: an integrated study of COASY-associated diseases
Cavestro, C, Morra, F, Legati, A, D'Amato, M, Nasca, A, Iuso, A, Lubarr, N, Morrison, JL, Wheeler, PG, Serra-Juhé, C, Rodríguez-Santiago, B, Turón-Viñas, E, Prouteau, C, Barth, M, Hayflick, SJ, Ghezzi, D, Tiranti, V, Di Meo, I. Emerging variants, unique phenotypes, and transcriptomic signatures: an integrated study of COASY-associated diseases. Annals of Clinical and Translational Neurology. 2024; 11(6)DOI:10.1002/acn3.52079. PMID:38750253. IF:3.900(Q1/3D).
01/06/2024 Esophageal desquamation in pediatrics. Esophagitis dissecans superficialis
Surinyac-Ayats, B, Font, SS, Betancourt, J, Szafranska, J, Boronat, S. Esophageal desquamation in pediatrics. Esophagitis dissecans superficialis. ANALES DE PEDIATRIA. 2024; 100(6)DOI:10.1016/j.anpedi.2024.02.013. PMID:38763790. IF:2.100(Q2/4D).
01/06/2024 miR-519a-3p, found to regulate cellular prion protein during Alzheimer 's disease pathogenesis, as a biomarker of asymptomatic stages
Jácome, D, Cotrufo, T, Andrés-Benito, P, Lidón, L, Martí, E, Ferrer, I, del Río, JA, Gavín, R. miR-519a-3p, found to regulate cellular prion protein during Alzheimer 's disease pathogenesis, as a biomarker of asymptomatic stages. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE. 2024; 1870(5)DOI:10.1016/j.bbadis.2024.167187. PMID:38653354. IF:4.200(Q1/2D).
01/06/2024 The efficacy of penile duplex ultrasound in erectile dysfunction management decision-making: facing the opinion leader
Cocci, A, Pezzoli, M, Lo Re, M, Ralph, D, Christopher, N, Osmonov, D, Bettocchi, C, Djinovic, R, Antonini, G, Levine, L, Salamanca, JIM, Otero, JR, Egydio, P, Iribarren, IM, Hatzichristodoulou, G, Perito, P, Antoine, F, Park, HJ, Rolle, L, Kadioglu, A, Ruíz-Castañé, E, Van Renterghem, K, Valenzuela, RJ, Wilson, SK, Tomada, N, Capece, M, Falcone, M. The efficacy of penile duplex ultrasound in erectile dysfunction management decision-making: facing the opinion leader. Journal of Mens Health. 2024; 20(6)DOI:10.22514/jomh.2024.084. PMID:. IF:0.600(Q4/10D).
01/06/2024 Determinants of Tricuspid Regurgitation Progression and Its Implications for Adequate Management
Bolumburu, AA, Ruiz, JMM, Mahia, P, David, EP, González, T, Sitges, M, Li, CH, Alonso, D, Carrasco, F, Morales, ML, Adeba, A, de la Hera, JM, Zamorano, JL. Determinants of Tricuspid Regurgitation Progression and Its Implications for Adequate Management. JACC-Cardiovascular Imaging. 2024; 17(6)DOI:10.1016/j.jcmg.2023.10.006. PMID:38069980. IF:15.200(Q1/1D).
01/06/2024 Meteorin-like plasma levels as a novel biomarker for heart failure
Feijoo-Bandin, S, Anido-Varela, L, Tarazón, E, Solé-González, E, Martínez-Sellés, M, Guerra-Ramos, JM, Carrasquer, A, Aragón-Herrera, A, Morán-Fernández, L, Moraña-Fernández, S, González-Maestro, A, García-Vega, D, Portolés, M, Roselló-Lleti, E, Lago, F, González-Juanatey, JR. Meteorin-like plasma levels as a novel biomarker for heart failure. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. 2024; 54DOI:. PMID:. IF:3.600(Q1/2D).